Skip to content

Does Induction Dosage in Latent Phase Affect Active Phase of Labor?

Does Induction Dosage in Latent Phase Affect Active Phase of Labor?A Randomized Study

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03742531
Enrollment
300
Registered
2018-11-15
Start date
2018-12-15
Completion date
2019-12-01
Last updated
2021-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Induction of Labor, Oxytocin

Brief summary

This study evaluates the need of oxytocin therapy in active phase of labor. there will be two groups treating with oxytocin in latent phase.One group will be treated with low dose oxytocin therapy and the other group will be treated with high dose oxytocin therapy. oxytocin treatment will be ceased at the beginning of the active phase of labor. the need of oxytocin treatment in active phase of labor will be compared between two groups.

Detailed description

Oxytocin treatment in active phase of labour is used with respect to clinicians preference and best approach has not been described. We want to investigate the effect of oxytocin treatment by using different regims in latent phase of labor when oxytocin treatment is ceased in active phase of labour. In our trial we discontinued oxytocin in active phase of labour and investigate which group needs oxytocin therapy due to inadequate uterine contractions and arrest of labor.

Interventions

DRUGoxytocin

one group will be treated with low dose oxytocin and the other group will be treated with high dose oxytocin for augmentation of labor induction.

Sponsors

Zeynep Kamil Maternity and Pediatric Research and Training Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Live fetus in cephalic presentation, sonographically estimated fetal weight less than 4200 g, undergoing induction of labor at 37-42 weeks of gestation, having indications of labor, no previous uterine surgery

Exclusion criteria

* malpresentation, placenta previa, previous uterine surgery, multiple gestation, active genital herpes, non-reassuring fetal heart rate pattern

Design outcomes

Primary

MeasureTime frameDescription
need for oxytocin retreatmentan average of one yearneed for oxytocin retreatment due to inadequate uterine contractions and labor arrest

Secondary

MeasureTime frameDescription
length of active phasean average of one yearduration of acive phase of labor
ratio of caesarean sectionan average of one yearcaesaraen section rate in total delivery
total oxytocin dosean average of one yeartotal amount of oxytocin treatment in latent and active phase of labor
APGAR scoresan average of one yearneonatal 1 minute and 5-minute-APGAR scores

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026